Ergolide

Ergolide
  • CAS No.:54999-07-4
  • Grade:99.48%
  • Formula:C17H22O5
  • M.W.:306.35
  • Solvent:≥ 2.5 mg/mL (8.16 mM); Clear solution

Overview

Ergolide is an orally active dual inhibitor targeting NF-κB/p65 and NLRP3 . Ergolide blocks the NF-κB signaling pathway and the nuclear translocation of p65 , and irreversibly binds to the NACHT domain of NLRP3 to inhibit inflammasome assembly. Ergolide significantly reduces the production of inflammatory mediators (e.g., NO, PGE 2 ) and cytokines, induces cancer cell apoptosis , autophagy and ROS generation. Ergolide also enhances the anti-tumor effect of vincristine. Ergolide alleviates acute lung injury via an NLRP3-dependent mechanism, and effectively improves the survival rate and behavioral function of septic mice and inflammatory zebrafish models. Ergolide is used in the research of metastatic uveal melanoma, neurodegenerative diseases (such as Alzheimer's disease, Parkinson's disease), sepsis and acute lymphoblastic leukemia.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Melanoma | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Blood Disease | Products > Disease Areas > Acute Lymphoblastic Leukemia | Products > Disease Areas > Metastatic Melanoma | Products > Disease Areas > Alzheimer's Disease | Products > Disease Areas > Parkinson's Disease | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > Immunology/Inflammation | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > NF-κB | Products > Signaling Pathways > NOD-like Receptor (NLR) | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Autophagy

Product Information

  • Catalog No.: HY-N6893
  • CAS No.: 54999-07-4
  • Molecular Formula: C17H22O5
  • Molecular Weight: 306.35
  • Purity: 99.48%
  • Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
  • Solubility: ≥ 2.5 mg/mL (8.16 mM); Clear solution
  • Availability: In-stock

Source

Original product source


您好!

感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。

  • 重庆市江北区五里店街道五江路18号
  • 023-6139-8061 13650506873
  • danny@chemdad.com sales@chemdad.com
  • www.chemdad.com
  • WhatsApp +86-13650506873

名字

电话

企业

邮箱

留言

Google translate: 日本语日本语 한국어한국어 FrançaisFrançais DeutschDeutsch EspañaEspaña TürkiyeTürkiye